期刊文献+

2型糖尿病患者一氧化氮及血小板活化异常与肾病的关系 被引量:7

The role of serum nitric oxide and platelet activation abnormity in diabetic nephropathy
暂未订购
导出
摘要 目的 探索一氧化氮 (NO)及血小板活化异常与糖尿病肾病 (DN)的关系。方法  74例 2型糖尿病 (DM)患者测定了血清 NO,其中 6 2例同时测定了血浆α-颗粒膜蛋白 (GMP140 )的水平 ,并依据 2 4小时尿白蛋白排出率(UAER)将其分为正常白蛋白尿组 (DM1 )、微量白蛋白尿组 (DM2 )、大量白蛋白尿组 (DM3 ) ,并与 37例正常人对照(NC)。结果 血清 NO在 DM1 较 NC明显升高 ,但 DM2 、DM3 却较 NC有显著性的降低 ;血浆 GMP140在 DM各组均较NC升高 ,特别是 DM2 、DM3 组较 NC明显升高。DM合并高血压者血 NO较无高血压者明显降低 ,而 GMP140均较无高血压者为高 (P<0 .0 5 )。血 NO与 GMP140呈显著负相关 (rs=- 0 .5 2 ,P<0 .0 5 )。结论  NO在 2型 DM早期升高 ,引起肾小球高灌注状态 ,后期下降 ,导致血小板活化增加。NO水平的异常及血小板活化的增强与 DN的发生。 Objective To explore the roles of nitric oxide(NO) and platelet activation abnormity in diabetic nephropathy(DN).Methods 74 type 2 diabetes mellitus(DM) patients were measured the levels of serum nitrites(NO - 2/NO - 3) a stable metabolic product of NO, and 62 among them were also determined the concentrations of GMP140(one of quota reflecting platelet activation) by ELISA. DM group were divided into three groups according to UAER(DM1: UAER <20ug/min, DM 2: UAER 20~200ug/min, DM3: UAER >200ug/min), and compared with 43 normal individuals(NC).Results Serum nitrites in DM1 were significantly higher than NC, but the NO levels of DM 2 and DM 3 were significantly lower than those; GMP140 in all of DM groups were higher than that in NC, espedaliy the DM 2 and DM3 were more increased than NC and DM1. NO in DM patients with hypertension were lower than that without hypertension, but GMP140 in DM patients with hypertension were higher than that without hypertension. There was significant negative correlation between NO and GMP140( r s=-0.52, P <0.05).Conclusion Elevated NO is related to renal hyperfiltration in early stage of DM. The decreased NO level in advanced DM may related to platelet activation, therefore promote the development of DN. The NO abnormity and the enbancement of platelet activation enhancement may be correlated with DN.
出处 《中国糖尿病杂志》 CAS CSCD 2001年第6期337-340,共4页 Chinese Journal of Diabetes
关键词 糖尿病肾病 血小板活化 一氧化氮 Diabetic nephropathy Platelet activation Nitric oxide
  • 相关文献

参考文献7

二级参考文献13

  • 1吴国新,阮长耿.^125I标记单抗夹心法测定血浆GMP—140及其临床应用[J].中华核医学杂志,1993,13(4):232-234. 被引量:11
  • 2石永兵,刘志达,韩惠琴,万海英.血小板α-颗粒膜蛋白在Ⅱ型糖尿病肾病早期诊断中的意义[J].肾脏病与透析肾移植杂志,1996,5(3):26-28. 被引量:5
  • 3阮长耿.血小板-基础与临床,第1版[M].上海:上海科学技术出版社,1985.174.
  • 4王振义.血栓与止血,第一版[M].上海:上海科学技术出版社,1988.294.
  • 5周鹏 陈南衡 等.-[J].中华肾脏病杂志,1998,14(1):57-57.
  • 6刘国良 陈晓晖.-[J].中华肾脏病杂志,1997,13(3):150-150.
  • 7阮长耿,血栓与止血.现代理论和临床实践,1994年,42页
  • 8黄葆钧,中华医学杂志,1984年,64卷,160页
  • 9祈忠华,中华内分泌代谢杂志,1998年,14卷,41页
  • 10Choi K C,Kidney Int,1997年,52卷,增刊,S23页

共引文献142

同被引文献60

  • 1程晖,贾汝汉.左旋-精氨酸对糖尿病肾病鼠的影响[J].武汉大学学报(医学版),2004,25(4):404-407. 被引量:7
  • 2吕学爱,关广聚,孙云,涂晓文,文蓉珠,柳刚.氨基胍对糖尿病大鼠肾脏蛋白激酶C活性的调节及意义[J].中华肾脏病杂志,2004,20(5):371-372. 被引量:6
  • 3童秋玲,许国英,吴钢.诱导型一氧化氮合酶与脑缺血[J].国外医学(脑血管疾病分册),2004,12(11):858-861. 被引量:8
  • 4廖琳,陈青,李国安,赵家军.一氧化氮和一氧化氮合酶基因多态性与糖尿病肾病[J].国外医学(内科学分册),2005,32(10):436-439. 被引量:8
  • 5全国眼底病协作组.糖尿病性视网膜病变分期标准[J].中华眼科杂志,1985,21:113-113.
  • 6[1]Hoehner CM,Greenlund KJ,Rith-najarian S,et al.Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans[J].Am Soc Nephrol,2002,13:1626-1634.
  • 7[2]Pedrinelli R,Dell'omol G,Bello V,et al.Microalbuminuria,an integrated marker of cardiovascular risk in essential hypertension[J].Hum Hypertens,2002,16:79-89.
  • 8[3]Jay PG,Geoge lb.Microalbuminuria:marker of vascular dysfunction,risk factor for cardiovascular disease[J].Vascular Medicine,2002,7:35-43.
  • 9[4]Breddin HK,Lippold R,Bittner M,et al.Spontaneous platelet aggregation as a predicitive risk factor for vascular occlusion in healthy volunteers? Results of the HAPARG study[J].Atherosclerosis,1999,144:211-219.
  • 10[5]Metzelaar MJ,Wijingaard PL,Peters PJ,et al.CD63 antigen,a novel lysosomal membrane glycoprotein cloned by a screening procedure for intracellular antigens in eukaryotic cells[J].Biol Chem,1990,70:838-849.

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部